N-Acetyl Epitalon Amidate

Behind the long name sits the same tetrapeptide as Epitalon, only locked at both ends: an acetyl group occupies the N-terminus and an amide the C-terminus. Both modifications shield the chain of alanine, glutamic acid, aspartic acid and glycine from peptidases, which is why the molecule survives considerably longer in the organism than the unaltered form from the Khavinson program.

For the activity itself, the literature draws on the data of the parent substance. Described there are:

• Activation of telomerase in somatic cells, including expression of the catalytic subunit and longer telomeres in telomerase-negative fibroblasts.
• Stimulation of melatonin release through the pineal gland; a 2003 paper compared this in young and old rats.
• General influences on aging processes along the epigenetic pathway the Khavinson group describes, plus lifespan and tumor findings in mice.
• Altered gene expression and protein synthesis during neurogenesis, published in 2020.

The acetylated and amidated variant is expected to deliver this pharmacology with better availability. That remains mostly an inference from the structure, though: direct head-to-head studies of the two forms are concentrated at the institute in St. Petersburg and have hardly been repeated elsewhere. In the protocols the peptide appears as a short series of ten to twenty days, repeated two or three times a year and given under the skin. It is supplied as a lyophilisate that is dissolved before use.

Because mechanism and safety picture are carried over from the parent substance, the variant counts as well tolerated in the literature. Four things are still worth keeping in view:

• Injection site: Redness, a feeling of tightness or a brief irritation are the most commonly named reactions.
• Circulation: Isolated reports describe a passing tiredness or mild warmth shortly after dosing.
• Thin comparison data: The acetylated form has even fewer independent investigations than Epitalon itself; most of them come from a single research institute, and independent replications are largely missing.
• No long-term observation in humans: The favourable picture rests on animal models and experience with the parent substance, not on multi-year human studies of the modified variant.

This summary is no substitute for medical advice.

• Epithalon Peptide Induces Telomerase Activity and Telomere Elongation in Human Somatic Cells - foundational paper of the Khavinson group on telomerase activation in human somatic cells.
• Effect of a synthetic pineal tetrapeptide (Ala-Glu-Asp-Gly) on melatonin secretion by the pineal gland of young and old rats - compares pineal melatonin output under AEDG in young and old animals.
• AEDG Peptide (Epitalon) Stimulates Gene Expression and Protein Synthesis during Neurogenesis - describes the tetrapeptide's influence on gene expression and protein synthesis during nerve cell development.